SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A minor change in the total revenue was seen in the June 2025 quarter. The total revenue for the quarter stood at Rs. 3324.43 millions against Rs. 3172.75 millions during year ago period.A humble growth in net profit of 7.15% reported in the quarter ended June 2025 to Rs. 448.67  millions from Rs. 418.75 millions.OP of the company witnessed a marginal growth to 726.63 millions from 698.59 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3324.43 3172.75 4.78 3324.43 3172.75 4.78 13117.84 14441.19 -9.16
Other Income 285.55 261.76 9.09 285.55 261.76 9.09 1241.92 941.21 31.95
PBIDT 726.63 698.59 4.01 726.63 698.59 4.01 2626.91 -325.37 -907.36
Interest 29.11 62.06 -53.09 29.11 62.06 -53.09 153.09 183.13 -16.40
PBDT 697.52 636.53 9.58 697.52 636.53 9.58 2473.82 -702.39 -452.20
Depreciation 102.46 93.82 9.21 102.46 93.82 9.21 395.45 326.94 20.95
PBT 595.06 542.71 9.65 595.06 542.71 9.65 2078.37 -1029.33 -301.91
TAX 146.39 123.96 18.09 146.39 123.96 18.09 468.39 625.18 -25.08
Deferred Tax -15.84 -1.27 1147.24 -15.84 -1.27 1147.24 -7.14 141.78 -105.04
PAT 448.67 418.75 7.15 448.67 418.75 7.15 1609.98 -1654.51 -197.31
Equity 306.21 286.13 7.02 306.21 286.13 7.02 306.21 286.13 7.02
PBIDTM(%) 21.86 22.02 -0.73 21.86 22.02 -0.73 20.03 -2.25 -988.80

Akums Drugs & Pharma Share Price

534.10 0.75 (0.14%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×